Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour ; day:22 ; month:8 ; year:2023 ; pages:1-19
Cellular oncology ; (22.8.2023), 1-19
- Creator
-
Zhang, Hanzhao
Konjusha, Dardan
Rafati, Nima
Tararuk, Tatsiana
Hallböök, Finn
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13402-023-00863-0
- URN
-
urn:nbn:de:101:1-2023110608493514201675
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Hanzhao
- Konjusha, Dardan
- Rafati, Nima
- Tararuk, Tatsiana
- Hallböök, Finn
- SpringerLink (Online service)
Other Objects (12)
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study
Low penetrance of retinoblastoma for p.V654L mutation of the RB1 gene
Regulation der Genexpression von MYCN in humanen Neuroblastomzellen durch Transkriptionsfaktoren der E2F-Familie
Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Five novel RB1 gene mutations and genotype–phenotype correlations in Chinese children with retinoblastoma
Neue Zielgene des Transkriptionsfaktors E2F-1 und die transkriptionelle Regulation des MYCN-Onkogens im humanen Neuroblastom
Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Retinoblastoma
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
RB1-Promotormethylierung bei Glioblastomen
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study
Low penetrance of retinoblastoma for p.V654L mutation of the RB1 gene
Regulation der Genexpression von MYCN in humanen Neuroblastomzellen durch Transkriptionsfaktoren der E2F-Familie
Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Five novel RB1 gene mutations and genotype–phenotype correlations in Chinese children with retinoblastoma
Neue Zielgene des Transkriptionsfaktors E2F-1 und die transkriptionelle Regulation des MYCN-Onkogens im humanen Neuroblastom
Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Retinoblastoma
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
RB1-Promotormethylierung bei Glioblastomen
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study
Low penetrance of retinoblastoma for p.V654L mutation of the RB1 gene
Regulation der Genexpression von MYCN in humanen Neuroblastomzellen durch Transkriptionsfaktoren der E2F-Familie
Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Five novel RB1 gene mutations and genotype–phenotype correlations in Chinese children with retinoblastoma
Neue Zielgene des Transkriptionsfaktors E2F-1 und die transkriptionelle Regulation des MYCN-Onkogens im humanen Neuroblastom
Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Retinoblastoma
Protein profiling of WERI-RB1 and etoposide-resistant WERI-ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma